Bank of New York Mellon’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,204
| Closed | -$39.4K | – | 4158 |
|
|
2023
Q4 | $39.4K | Hold |
16,204
| – | – | ﹤0.01% | 4173 |
|
|
2023
Q3 | $32.7K | Sell |
16,204
-74
| -0.5% | -$149 | ﹤0.01% | 4200 |
|
|
2023
Q2 | $48K | Sell |
16,278
-94,087
| -85% | -$278K | ﹤0.01% | 4174 |
|
|
2023
Q1 | $276K | Sell |
110,365
-1,705
| -2% | -$4.26K | ﹤0.01% | 3778 |
|
|
2022
Q4 | $355K | Buy |
112,070
+2,274
| +2% | +$7.21K | ﹤0.01% | 3718 |
|
|
2022
Q3 | $326K | Buy |
109,796
+15,496
| +16% | +$46K | ﹤0.01% | 3788 |
|
|
2022
Q2 | $287K | Sell |
94,300
-10,518
| -10% | -$32K | ﹤0.01% | 3905 |
|
|
2022
Q1 | $1.42M | Buy |
104,818
+960
| +0.9% | +$13K | ﹤0.01% | 3109 |
|
|
2021
Q4 | $1.35M | Buy |
103,858
+6,457
| +7% | +$84.1K | ﹤0.01% | 3212 |
|
|
2021
Q3 | $914K | Buy |
97,401
+14,131
| +17% | +$133K | ﹤0.01% | 3437 |
|
|
2021
Q2 | $853K | Buy |
83,270
+47,592
| +133% | +$488K | ﹤0.01% | 3511 |
|
|
2021
Q1 | $656K | Sell |
35,678
-4,293
| -11% | -$78.9K | ﹤0.01% | 3541 |
|
|
2020
Q4 | $1.37M | Buy |
+39,971
| New | +$1.37M | ﹤0.01% | 3060 |
|